On 16 July 2014
Sun Pharmaceutical Industries announced the acquisition of Pharmalucence Inc., by one of its subsidiaries. Pharmalucence has sterile injectable capacity in the US, supported by strong R&D capabilities.Powered by Capital Market - Live News
